Immediate Impact
1 by Nobel laureates 2 from Science/Nature 51 standout
Citing Papers
Machine learning in point-of-care testing: innovations, challenges, and opportunities
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Works of Celeste Cagnazzo being referenced
383O MAYA trial: Temozolomide (TMZ) priming followed by combination with low-dose ipilimumab and nivolumab in patients with microsatellite stable (MSS), MGMT silenced metastatic colorectal cancer (mCRC)
2021
A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Celeste Cagnazzo | 451 | 76 | 47 | 173 | 133 | 50 | 720 | |
| Mehran Habibi | 246 | 56 | 12 | 210 | 96 | 63 | 822 | |
| Dimitra Grapsa | 260 | 33 | 1 | 168 | 136 | 75 | 805 | |
| Yize Mao | 509 | 49 | 12 | 226 | 117 | 38 | 814 | |
| Vincenzo Montesarchio | 360 | 25 | 35 | 103 | 223 | 69 | 812 | |
| Tao Xia | 222 | 57 | 1 | 194 | 106 | 59 | 719 | |
| Vanessa E. Kennedy | 219 | 94 | 2 | 167 | 100 | 42 | 801 | |
| John Kit Chung Tam | 141 | 61 | 4 | 150 | 182 | 52 | 791 | |
| Georg Pall | 354 | 55 | 9 | 72 | 189 | 49 | 789 | |
| Ian Nivison‐Smith | 277 | 128 | 3 | 118 | 70 | 39 | 844 | |
| Wei Li | 190 | 27 | 4 | 205 | 295 | 48 | 716 |
All Works
Login with ORCID to disown or claim papers
Loading papers...